Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisomal biogenesis factor 5-like protein (PEX5L) is a member of the peroxin (PEX) family, which are proteins essential for assembly and maintenance of peroxisomes in eukaryotic cells[1][3]. While canonical PEX5 is established as the receptor for proteins containing peroxisomal targeting signal 1 (PTS1), necessary for their import into the peroxisomal matrix, the "peroxisomal biogenesis factor 5-like" (PEX5L) nomenclature actually denotes a related gene distinct from PEX5 itself. In mammals, PEX5L/TRIP8b is better known as the tetratricopeptide repeat-containing Rab8b-interacting protein (TRIP8b), which acts as an auxiliary subunit regulating HCN channel trafficking and function in neurons, playing no direct role in peroxisome biogenesis[1]. PEX5L/TRIP8b modulates neuronal excitability by controlling the surface expression and gating of HCN channels (hyperpolarization-activated cyclic nucleotide-gated channels). Though its gene structure resembles that of peroxins, it is not considered a canonical peroxisomal import receptor, nor is it known as a therapeutic drug target or receptor in the classical sense[1][4]. PX5L is frequently misattributed as a peroxisome biogenesis factor or direct drug target, but in current human nomenclature TRIP8b/PEX5L primarily regulates HCN channel function in the nervous system and is not a recognized therapeutic target or biomarker. Some genetic studies report associations between PEX5L variants and Alzheimer's disease risk, but no drug interactions, mechanisms of action, or safety concerns are documented[4]. Note: The search results and literature indicate confusion between PEX5 (the established peroxisome receptor) and PEX5L/PEX5R/TRIP8b (an unrelated neuronal regulatory protein), hence the entry is marked "is_incorrect: true" for purposes where only validated molecular targets (enzymes, receptors, ion channels, etc.) are considered. If you require information about PEX5 (canonical peroxisomal import receptor), please specify; otherwise, "PEX5L" predominantly refers to TRIP8b in current molecular biology, not a therapeutic target[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal biogenesis factor 5-like protein (PEX5L).